ENHANCED SENSITIVITY OF BLADDER CANCER CELLS TO CISPLATIN MEDIATED CYTOTOXICITY AND APOPTOSIS IN VITRO AND IN VIVO BY THE SELECTIVE CYCLOOXYGENASE-2 INHIBITOR JTE-522
Authors:
- 1 October 2004
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 172 (4 Part 1) , 1474-1479
Abstract
Purpose: Cyclooxygenase-2 (COX-2) is a key inducible enzyme involved in the production of prostaglandins and its inhibitors have been shown to induce apoptosis in various cancer cells. Seve...Keywords
This publication has 13 references indexed in Scilit:
- The Coxibs, Selective Inhibitors of Cyclooxygenase-2New England Journal of Medicine, 2001
- Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladderCancer, 2001
- ENHANCED SENSITIVITY OF BLADDER CANCER CELLS TO TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND MEDIATED APOPTOSIS BY CISPLATIN AND CARBOPLATINJournal of Urology, 2001
- COX-2 Inhibitors – Is there cause for concern?Nature Medicine, 1999
- Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part II)JNCI: Journal of the National Cancer Institute, 1998
- Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)JNCI: Journal of the National Cancer Institute, 1998
- Profile of JTE-522 as a Human Cyclooxygenase-2 InhibitorThe Japanese Journal of Pharmacology, 1998
- Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicityCancer, 1997
- Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)Cell, 1996
- Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.Proceedings of the National Academy of Sciences, 1994